Renascience Inc. Renascience Inc.

Renascience Inc.

4889

Rank in Stocks #20843
Renascience Inc., established in 2000 and based in Tokyo, Japan, is actively... Renascience Inc., established in 2000 and based in Tokyo, Japan, is actively engaged in pioneering and bringing to market pharmaceuticals and medical devices throughout Japan. The company's pipeline includes RS5614, a PAI-1 inhibitor that has reached Phase 3 clinical trials for a wide range of indications such as chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, novel coronavirus infections, and FGF23-related hypophosphatemic rickets. Another PAI-1 inhibitor, RS5441, is currently in Phase 1 trials for various dermatological conditions. Additionally, RS8001, a water-soluble vitamin, is undergoing Phase 2 clinical development for the treatment of premenstrual syndrome/premenstrual dysphoric mood disorder, autism spectrum disorder, and menopausal disorder. Beyond its pharmaceutical ventures, Renascience is also advancing the RS9001 disposable ultrafine endoscope, alongside developing artificial intelligence-driven medical solutions and comprehensive diagnostic tools.
Share Price
$5.60
Last synced: 2026-11-13
Market Cap
$77.19M
Change (1 day)
-0.46%
Change (1 year)
-53.99%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Renascience Inc. (4889)
Operating Margin as of November 2026 TTM: -481.16%
According to Renascience Inc.'s latest financial reports, its current operating margin (TTM) is -481.16%. At the end of 2025 the company had an operating margin of -134.77%.
Operating Margin history for Renascience Inc. from 2020 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -481.16% 257.02%
2025 -134.77% 3.70%
2024 -129.96% -60.86%
2023 -332.06% 119.44%
2022 -151.32% 268.62%
2021 -41.05% -83.85%
2020 -254.17% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -99.59%
US
33.87% -100.07%
US
-116.04% -99.76%
US
25.57% -100.05%
AU
31.23% -100.06%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Renascience Inc.'s operating margin

What is Renascience Inc.'s operating margin?

Renascience Inc.'s operating margin is -481.16%, as of Nov 2026.

What was Renascience Inc.'s operating margin in 2025?

In 2025, Renascience Inc.'s operating margin was -134.77%, compared with -129.96% in 2024.

How has Renascience Inc.'s operating margin changed since 2020?

From 2020 to 2025, Renascience Inc.'s operating margin was highest in 2021 (-41.05%) and lowest in 2023 (-332.06%).

How does Renascience Inc.'s operating margin compare with similar companies?

Renascience Inc.'s operating margin (-481.16%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.